Also Read
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
LIVE
Can Paxlovid Treat COVID-19 Infection? WHO Releases New Guidelines
The World Health Organisation (WHO) has released a set of new safety guidelines amid a massive COVID-19 resurgence in China. The global health body has recommended the use of face masks at all times when stepping out of the house or getting inside a closed zone with more than a few people. In a statement, WHO said, "Masks are recommended following recent exposure to COVID-19 when someone has or suspects they have COVID-19 when someone is at high risk of severe COVID-19, and for anyone in a crowded, enclosed, or poorly ventilated space."
In the same set of guidelines, WHO reviewed the treatment options available for patients catching COVID-19 infection. The global health body has extended its strong recommendation for the use of nirmatrelvir-ritonavir, also known by the name Paxlovid. Nirmatrelvir-ritonavir, or Paxlovid is the first-ever recommended medicine for COVID-19 infection by the WHO. The global health body had recommended the use of this drug for COVID-19 patients who are at high risk of hospitalisation. However, pregnant or breastfeeding women with COVID-19 must consult with their doctor about whether they are allowed to take this drug.
The third most important COVID-safety guideline was about the isolation period. In a recent recommendation, the WHO stated that a COVID-19 patient can be discharged from isolation early if they test negative on an antigen-based rapid test. Without testing the isolation period will be 5 days from the date of symptom onset.
Also Read
Also Read
Also Read
Follow this space to stay updated with all the latest developments on COVID-19.